EN / CN
CompanyFoundersCore ValuesMilestones

Company

Founded in 2011, Leapmed is a medical technology company providing comprehensive solutions for ultrasound-guided accurate interventions. With headquarters in Suzhou, Leapmed has subsidiary companies of Leapmed France, Leapmed Beijing and Yuxin Medical, We have a professional teams of product research & development, production and marketing.

After years of cultivation in the industry, Leapmed has 100+ domestic and international patents and 30+ CFDA and FDA devices registration certifications. Leapmed now is a competitive brand in the world. Leapmed has independently developed “Disposable Ultrasound Intervention” consumables and various biopsy solutions. Prodcut pipelines include disposable X-needle guides , disposable biopsy instruments, disposable puncture needles, sterile ultrasound gels, and sterile probe covers, etc., which are used for ultrasound-guided biopsy (including thyroid, lymph, breast, liver and gall, kidney and urology department), assisted reproduction and visualized anesthesia surgery (nerve block). Our products have been sold in more than 40 countries worldwide and been used in more than 300 Grade III Level A hospitals in China. With the continuous innovation of cutting-edge technology by the R&D team, Leapmed will continuously provide more accurate and safer solutions to the global image-guided intervention industry.

Culture

Adhering to the tenet of “Care for life, Quality first”,

Leapmed will strive tirelessly for human health.

Suzhou Leapmed Healthcare Corporation
Vision

Be the leader in medical devices for image-guided intervention

Mission

Make image-guided intervention safer and more convenient

Founders

  • Suzhou Leapmed Healthcare Corporation

    Baozhong Wang

    Founder/Executive Chairman of Leapmed
    Founder of Leapmed in 1994; 20+ years of experience in the ultrasound industry
    Member of Specialized Instrument Development Committee of Chinese Association of Ultrasound in Medicine and Engineering (CAUME) in 2012
    Vice Chairman of a Specialized Committee of JingSu Association of Ultrasound in Medicine and Engineering (JSAUME) in 2013
    Member of China Association of Ultrasound in Medical Equipment in 2015
    The first author of YY/T 1671—2020 Ultrasound Biopsy Guide (National industrial standard )
  • Suzhou Leapmed Healthcare Corporation

    Leah Wang

    General Manager
    Majored in international shipping management
    Work experience in a international shipping company
    6 SIGMA green belt
    Founder of Leapmed, leading the team to the world
    Years of experience in medical industry

Core Values

Milestones

1994
2007
2011
2012
2015
2016
2017
2018
2019
2020
2021
2022
1994

WilliamWang founded Leapmed -- the first company in China that specializes in medical ultrasound technology and product services.

2007

Leapmed is the first company in China that leads to the inclusion of “Ultrasound Biopsy Needle Guide” in the CFDA catalog.

2011

1. In May, Suzhou Leapmed Healthcare Corporation was founded in Suzhou by co-founders: William Wang and Leah Wang. 2. Leapmed was the first Ultrasound Biopsy Needle Guide R&D Center in China, which completed the R&D of 100+ models and specifications of biopsy needle guides that are compatible with ultrasound systems of many brands at home and abroad.

2012

Leapmed was the first company in China to obtain CFDA registration certificates for its “Ultrasound Biopsy Guides”

2015

1. The biopsy needle guide is certified by CE and ISO 13485 standards. 2. Obtained a total of 17 patents. 3. Completed the R&D and clinical verification of more than 250 products. 4. Established standardized plants.

2016

1、Leapmed was the first supplier in China for GE ultrasound biopsy needle guide FMD products certified by GE (exclusive in China) 2. Obtained a total of 23 patents. 3. Established Leapmed France in Toulouse, France; Set up the European team, and sold biopsy guides in the international market. 4. Established GMP workshops.

2017

1. Leapmed Obtained the first registration certificate for “Ultrasound Biopsy Needle Guide” issued by CFDA in China 2. Obtained a total of 27 patents. 3. The R&D teams cooperated with more than 10 companies and hospitals worldwide to synchronize R&D with international team. 4. The “Morning Star Standardized Training for Interventional Ultrasound” co-organized by Leapmed and Chinese Society of Ultrasound in Medicine of Chinese Medical Association was officially initiated. The first season was successfully held in 5 major cities and 10+ provinces and cities in China.

2018

1. Leapmed Obtained the certificate of “National High-tech Enterprise”. 2. “Suzhou Engineering Technology Research Center for Ultrasound Intervention Products” was established in Leapmed. 3. Leapmed obtained a total of 35 patents. 4. The second “Morning Star Training Program” gained an unprecedented success, with 29 sessions held in 24 provinces and cities. 5. Leapmed signed a strategic alliance agreement with Fujifilm of Japan, and promoted the integrated solution of “Precise visualized anesthesia” in China for the first time.

2019

1. The first disposable biopsy needle & puncture needle independently developed and produced by Leapmed obtained the registration certificate approved by CFDA. 2. Leapmed obtained a total of 51 patents. 3. Established the U.S. R&D and Production Center to activate the North American market. 4. Elected as the “Specialized, Refined, Differential and Innovative” enterprise of Suzhou City.

2020

1. YY/T 1671-2020 Ultrasound biopsy needle guide, a national industry standard of China, was drafted by Leapmed (the only entity enterprise) and officially released for implementation. 2. Leapmed obtained a total of 65 patents. 3. The drainage catheter developed by Leapmed obtained the registration certificate from CFDA. 4. The products of Leapmed were used by 200 Grade III Level A hospitals in more than 30 provinces and cities in China. 5. ESG social responsibility: Leapmed donated infection control consumables worth more than one million yuan to the COVID-19 epidemic area.

2021

1. The first “Disposable Automatic Core Biopsy Instrument” of China was certified by the U.S. FDA. The biopsy instrument series was launched to the international market. 2. The biopsy needle guide products were purchased by U.S. TOP hospitals such as Mayo Clinic, Cleveland, and Hopkins. 3. The patents for invention of many core products were licensed by the Patent Office of the United States, the United Kingdom, France, Italy, and Germany, etc. 4. Leapmed was licensed 11 international patents for invention as per PCT. 5. Obtained a total of 113 patents. 6. Leapmed was awarded the “National High-Tech Enterprise” for a second time. 7. The 3rd “Morning Star” Training was conducted, to continuously promote the application and academic development of ultrasound intervention technology in China.

2022

Moved to Medpark (Incubator) in Suzhou New District, officially entering the era of Leapmed 2.0.